menu
    • menu

    Company profile for Nouscom AG

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nouscom is a private oncology company developing next generation immunotherapies. Nouscom’s proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an experienced management team that has worked together for many years in previous successful enterprises, including IRBM/Merck and Okairo...
    Nouscom is a private oncology company developing next generation immunotherapies. Nouscom’s proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an experienced management team that has worked together for many years in previous successful enterprises, including IRBM/Merck and Okairos (acquired by GSK), and are veterans in the field of genetic vaccines.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nouscom AGSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Bäumleingasse 18 BS, Basel-City 4051
    Telephone
    Telephone
    41612011831
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.nouscom.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/nouscom-ag
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nouscom Unveils Positive Phase 1/2B Data For NOUS-209 At SITC
    Nouscom Unveils Positive Phase 1/2B Data For NOUS-209 At SITC

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183707/0/en/Nouscom-Presents-New-Positive-Phase-1-2b-data-of-NOUS-209-at-SITC-2025-Supporting-Plans-to-Initiate-Registration-Enabling-Study-for-Cancer-Interception-in-Lynch-Syndrome-Carriers.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Nouscom to Present Ph 1b/2 NOUS-209 Data in Lynch Syndrome
    Nouscom to Present Ph 1b/2 NOUS-209 Data in Lynch Syndrome

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177455/0/en/Nouscom-to-Present-New-Positive-Phase-1b-2-Clinical-and-Translational-Data-on-NOUS-209-Immunogenicity-and-Cancer-Interception-Potential-in-Lynch-Syndrome-Carriers-at-SITC-2025.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Nouscom Reveals NOUS-209 Immunotherapy Success In MSI-H Cancer
    Nouscom Reveals NOUS-209 Immunotherapy Success In MSI-H Cancer

    12 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/12/3165248/0/en/Nouscom-Presents-Positive-Phase-2-Results-of-NOUS-209-Immunotherapy-Combined-with-Pembrolizumab-in-MSI-H-Metastatic-Colorectal-Cancer-Patients-Refractory-to-Anti-PD-1-Therapy-at-ES.html

    GLOBENEWSWIRE
    12 Oct 2025
    Share Share
    Nouscom’s NOUS-209 Shows Durable Response in Lynch Syndrome
    Nouscom’s NOUS-209 Shows Durable Response in Lynch Syndrome

    29 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/29/3070727/0/en/Nouscom-Presents-Positive-Final-Results-from-Completed-Phase-Ib-II-Study-of-Neoantigen-Immunotherapy-NOUS-209-at-AACR-2025-Demonstrating-a-Highly-Potent-and-Durable-Immune-Response.html

    GLOBENEWSWIRE
    29 Apr 2025
    Share Share
    Nouscom To Present Ph Ib/II NOUS-209 Data In Lynch Syndrome At AACR
    Nouscom To Present Ph Ib/II NOUS-209 Data In Lynch Syndrome At AACR

    25 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/25/3049177/0/en/Nouscom-to-Present-Final-Results-from-Successful-Phase-Ib-II-Trial-of-NOUS-209-in-People-Living-with-Lynch-Syndrome-Demonstrating-Powerful-Potential-to-Intercept-Cancer-in-its-Earl.html

    GLOBENEWSWIRE
    25 Mar 2025
    Share Share
    Nouscom Completes Enrollment of NOUS-209 in dMMR/MSI CRC
    Nouscom Completes Enrollment of NOUS-209 in dMMR/MSI CRC

    19 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/19/2983284/0/en/Nouscom-Completes-Patient-Enrollment-of-Randomized-Phase-2-Study-Evaluating-NOUS-209-an-Off-the-Shelf-Neoantigen-Immunotherapy-in-dMMR-MSI-Metastatic-Colorectal-Cancer.html

    GLOBENEWSWIRE
    19 Nov 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search